BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18836286)

  • 1. Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification.
    Chen S; Auletta T; Dovirak O; Hutter C; Kuntz K; El-ftesi S; Kendall J; Han H; Von Hoff DD; Ashfaq R; Maitra A; Iacobuzio-Donahue CA; Hruban RH; Lucito R
    Cancer Biol Ther; 2008 Nov; 7(11):1793-802. PubMed ID: 18836286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification.
    Heidenblad M; Jonson T; Mahlamäki EH; Gorunova L; Karhu R; Johansson B; Höglund M
    Genes Chromosomes Cancer; 2002 Jun; 34(2):211-23. PubMed ID: 11979555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma.
    Begum A; Imoto I; Kozaki K; Tsuda H; Suzuki E; Amagasa T; Inazawa J
    Cancer Sci; 2009 Oct; 100(10):1908-16. PubMed ID: 19594544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer.
    Mahlamäki EH; Kauraniemi P; Monni O; Wolf M; Hautaniemi S; Kallioniemi A
    Neoplasia; 2004; 6(5):432-9. PubMed ID: 15548351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration.
    King H; Thillai K; Whale A; Arumugam P; Eldaly H; Kocher HM; Wells CM
    Sci Rep; 2017 Feb; 7():42575. PubMed ID: 28205613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets.
    Qian Z; Zhu G; Tang L; Wang M; Zhang L; Fu J; Huang C; Fan S; Sun Y; Lv J; Dong H; Gao B; Su X; Yu D; Zang J; Zhang X; Ji J; Ji Q
    Genes Chromosomes Cancer; 2014 Nov; 53(11):883-94. PubMed ID: 24935174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of genomic DNA alterations and mRNA expression patterns in a panel of human pancreatic cancer cell lines.
    Gysin S; Rickert P; Kastury K; McMahon M
    Genes Chromosomes Cancer; 2005 Sep; 44(1):37-51. PubMed ID: 15929091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy number alterations of chromosomal regions enclosing protein tyrosine phosphatase receptor-like genes in colorectal cancer.
    Laczmanska I; Karpinski P; Kozlowska J; Bebenek M; Ramsey D; Sedziak T; Ziolkowski P; Sasiadek MM
    Pathol Res Pract; 2014 Dec; 210(12):893-6. PubMed ID: 25169130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer.
    Miwa W; Yasuda J; Murakami Y; Yashima K; Sugano K; Sekine T; Kono A; Egawa S; Yamaguchi K; Hayashizaki Y; Sekiya T
    Biochem Biophys Res Commun; 1996 Aug; 225(3):968-74. PubMed ID: 8780719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification.
    Kuuselo R; Savinainen K; Azorsa DO; Basu GD; Karhu R; Tuzmen S; Mousses S; Kallioniemi A
    Cancer Res; 2007 Mar; 67(5):1943-9. PubMed ID: 17332321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization.
    Suzuki A; Shibata T; Shimada Y; Murakami Y; Horii A; Shiratori K; Hirohashi S; Inazawa J; Imoto I
    Cancer Sci; 2008 May; 99(5):986-94. PubMed ID: 18380791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma.
    Lehnen NC; von Mässenhausen A; Kalthoff H; Zhou H; Glowka T; Schütte U; Höller T; Riesner K; Boehm D; Merkelbach-Bruse S; Kirfel J; Perner S; Gütgemann I
    Histopathology; 2013 Aug; 63(2):157-66. PubMed ID: 23808822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging human pancreatic cancer xenografts by targeting mutant KRAS2 mRNA with [(111)In]DOTA(n)-poly(diamidopropanoyl)(m)-KRAS2 PNA-D(Cys-Ser-Lys-Cys) nanoparticles.
    Amirkhanov NV; Zhang K; Aruva MR; Thakur ML; Wickstrom E
    Bioconjug Chem; 2010 Apr; 21(4):731-40. PubMed ID: 20232877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of DNA sequences from chromosome 19q13.1 in human pancreatic cell lines.
    Curtis LJ; Li Y; Gerbault-Seureau M; Kuick R; Dutrillaux AM; Goubin G; Fawcett J; Cram S; Dutrillaux B; Hanash S; Muleris M
    Genomics; 1998 Oct; 53(1):42-55. PubMed ID: 9787076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of genomic alterations in pancreatic cancer using array-based comparative genomic hybridization.
    Liang JW; Shi ZZ; Shen TY; Che X; Wang Z; Shi SS; Xu X; Cai Y; Zhao P; Wang CF; Zhou ZX; Wang MR
    PLoS One; 2014; 9(12):e114616. PubMed ID: 25502777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p21-activated kinase 4: a druggable target in the elusive oncogenic KRAS pathway?
    Azmi AS; Mohammad RM
    Future Med Chem; 2015; 7(1):5-7. PubMed ID: 25582328
    [No Abstract]   [Full Text] [Related]  

  • 18. Pancreatic cancer DNMT1 expression and sensitivity to DNMT1 inhibitors.
    Li A; Omura N; Hong SM; Goggins M
    Cancer Biol Ther; 2010 Feb; 9(4):321-9. PubMed ID: 20234167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene.
    Wallrapp C; Müller-Pillasch F; Solinas-Toldo S; Lichter P; Friess H; Büchler M; Fink T; Adler G; Gress TM
    Cancer Res; 1997 Aug; 57(15):3135-9. PubMed ID: 9242439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer.
    Mahlamäki EH; Bärlund M; Tanner M; Gorunova L; Höglund M; Karhu R; Kallioniemi A
    Genes Chromosomes Cancer; 2002 Dec; 35(4):353-8. PubMed ID: 12378529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.